Abstract
Both virus like particles (VLPs) and virus nanoparticles (VNPs) are viable platforms for the transportation of drugs, imaging agents, immunogenic ligands and other materials. They can be loaded with genetic material and/or drugs for therapeutic purposes. VLPs possess multivalent molecular settings, which help stimulate various molecular interactions for a potent immune response. VNPs are biodegradable and biocompatible nanoparticles that occur in nature and can be modified with genetic and chemical protocols for therapeutic purposes. There has been considerable research on the use of different VLPs and VNPs as safe and viable platforms for vaccine development, tumor therapy and other medical applications. The following chapter provides insight into applications of plant VLPs and VNPs in medicine.
Keywords: Chimeric VLP, Vaccines, Virus like particles (VLPs), Virus nanoparticles (VNPs), Plant-derived vaccine.
Related Journals
Applied Drug Research, Clinical Trials and Regulatory Affairs
Drug Delivery Letters
Current Bioactive Compounds
Reviews on Recent Clinical Trials
Current Drug Delivery
Current Drug Safety
Drug Metabolism and Bioanalysis Letters
Recent Advances in Drug Delivery and Formulation
Recent Advances in Anti-Infective Drug Discovery
Current Drug Targets - Inflammation & Allergy
Related Books
A Comprehensive Text Book on Self-emulsifying Drug Delivery Systems
Angiogenesis & Therapeutic Targets In Cancer
Anti-Angiogenesis Drug Discovery and Development
Anti-Angiogenesis Drug Discovery and Development
Anti-Angiogenesis Drug Discovery and Development
Anti-Angiogenesis Drug Discovery and Development
Anti-Angiogenesis Drug Discovery and Development
Biopolymers In Drug Delivery: Recent Advances and Challenges
Chemoinformatics: Directions Toward Combating Neglected Diseases
Current Advances in Drug Delivery Through Fast Dissolving/Disintegrating Dosage Forms